» Articles » PMID: 34315538

Current Insights into the Implications of M6A RNA Methylation and Autophagy Interaction in Human Diseases

Overview
Journal Cell Biosci
Publisher Biomed Central
Specialty Biology
Date 2021 Jul 28
PMID 34315538
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a conserved degradation process crucial to maintaining the primary function of cellular and organismal metabolism. Impaired autophagy could develop numerous diseases, including cancer, cardiomyopathy, neurodegenerative disorders, and aging. N6-methyladenosine (m6A) is the most common RNA modification in eukaryotic cells, and the fate of m6A modified transcripts is controlled by m6A RNA binding proteins. m6A modification influences mRNA alternative splicing, stability, translation, and subcellular localization. Intriguingly, recent studies show that m6A RNA methylation could alter the expression of essential autophagy-related (ATG) genes and influence the autophagy function. Thus, both m6A modification and autophagy could play a crucial role in the onset and progression of various human diseases. In this review, we summarize the latest studies describing the impact of m6A modification in autophagy regulation and discuss the role of m6A modification-autophagy axis in different human diseases, including obesity, heart disease, azoospermatism or oligospermatism, intervertebral disc degeneration, and cancer. The comprehensive understanding of the m6A modification and autophagy interplay may help in interpreting their impact on human diseases and may aid in devising future therapeutic strategies.

Citing Articles

Integrating bulk and single-cell RNA sequencing data: unveiling RNA methylation and autophagy-related signatures in chronic obstructive pulmonary disease patients.

Liao S, Zhang L, Shi L, Hu H, Gu Y, Wang T Sci Rep. 2025; 15(1):4005.

PMID: 39893187 PMC: 11787343. DOI: 10.1038/s41598-025-87437-2.


The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies.

Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.

PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.


The Emerging Role of IGF2BP2 in Cancer Therapy Resistance: From Molecular Mechanism to Future Potential.

Li D, Hu S, Ye J, Zhai C, Liu J, Wang Z Int J Mol Sci. 2024; 25(22).

PMID: 39596216 PMC: 11595103. DOI: 10.3390/ijms252212150.


STM2457 Inhibits METTL3-Mediated m6A Modification of miR-30c to Alleviate Spinal Cord Injury by Inducing the ATG5-Mediated Autophagy.

Chen G, Shangguan Z, Ye X, Chen Z, Li J, Liu W Neurospine. 2024; 21(3):925-941.

PMID: 39363472 PMC: 11456927. DOI: 10.14245/ns.2448494.247.


Role of N6-methyladenosine RNA modification in cancer.

Qu Y, Gao N, Zhang S, Gao L, He B, Wang C MedComm (2020). 2024; 5(9):e715.

PMID: 39252821 PMC: 11381670. DOI: 10.1002/mco2.715.


References
1.
Zheng G, Dahl J, Niu Y, Fedorcsak P, Huang C, Li C . ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2012; 49(1):18-29. PMC: 3646334. DOI: 10.1016/j.molcel.2012.10.015. View

2.
Qin Y, Li L, Luo E, Hou J, Yan G, Wang D . Role of m6A RNA methylation in cardiovascular disease (Review). Int J Mol Med. 2020; 46(6):1958-1972. PMC: 7595665. DOI: 10.3892/ijmm.2020.4746. View

3.
Cheung M, Gulati P, ORahilly S, Yeo G . FTO expression is regulated by availability of essential amino acids. Int J Obes (Lond). 2012; 37(5):744-7. DOI: 10.1038/ijo.2012.77. View

4.
Piya S, Andreeff M, Borthakur G . Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia. Autophagy. 2016; 13(1):214-215. PMC: 5240828. DOI: 10.1080/15548627.2016.1245263. View

5.
Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View